Search bioRxiv⌕ Search

Biology subjects

Thrush, R. J.

Publications and source records attributed to Thrush, R. J..

2 recordsLinked to original sources

Amyloid-β Oligomers Serve as Nucleation Sites for α-Synuclein Aggregation

An increasing number of cases where amyloids of different proteins are found in the same patient are being reported. This observation complicates diagnosis and clinical intervention. Amyloids of the amyloid-{beta} peptide or the protein -synuclein are traditionally considered hallmarks of Alzheimers and Parkinsons diseases, respectively. However, the co-occurrence of amyloids of these proteins has also been reported in patients diagnosed with either disease. Here, we show that soluble species containing amyloid-{beta} can induce the aggregation of -synuclein. Fibrils formed under these conditions are solely composed of -synuclein to which amyloid-{beta} can be found associated, but not as part of the core of the fibrils. Importantly, by global kinetic analysis, we found that the aggregation of -synuclein under these conditions occurs via heterogeneous primary nucleation, triggered by soluble aggregates containing amyloid-{beta}.

biochemistry↗

A Facile Method to Produce N-Terminally Truncated α-Synuclein

-Synuclein is a key protein of the nervous system, which regulates the release and recycling of neurotransmitters in the synapses. It is also involved in several neurodegenerative conditions, including Parkinsons disease and Multiple System Atrophy, where it forms toxic aggregates. The N-terminus of -synuclein is of particular interest as it has been linked to both the physiological and pathological functions of the protein and undergoes post-translational modification. One such modification, N-terminal truncation, affects the aggregation propensity of the protein in vitro and is also found in aggregates from patients brains. To date, our understanding of the role of this modification has been limited by the many challenges of introducing biologically relevant N-terminal truncations with no overhanging starting methionine. Here, we present a method to produce N-terminally truncated variants of -synuclein that do not carry extra terminal residues. We show that our method can generate highly pure protein to facilitate the study of this modification and its role in physiology and disease. Thanks to this method, we have determined that the first six residues of -synuclein play an important role in the formation of the amyloids.

biochemistry↗